Dental and medical products company Henry Schein (NASDAQ:HSIC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 6.7% year on ...
What Happened? Shares of dental and medical products company Henry Schein (NASDAQ:HSIC) jumped 2.8% in the afternoon session after the company reported secon...
Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings g
Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year ...
Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday before the bell. Here’s what you need to know. Henry Sc...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor exec...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its ...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Henry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.2% to $81.6...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Henry Schein (NASDAQ:HSIC) executives said the company is on track with its 2026 commitments and value-creation plan, while pointing to continued momentum in the U.S. dental market despite broader concerns about consumer confidence.
Speaking at a Stifel dental track event moderated by Stifel Managi
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season.
Speaking at a Bank of America h
Henry Schein’s first quarter results were well received by the market, with outperformance driven by robust gains in U.S. dental and global technology segmen...
Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 6.3% year...
Dental and medical products company Henry Schein (NASDAQ:HSIC) announced better-than-expected revenue in Q1 CY2026, with sales up 6.3% year on year to $3.37 ...
